Fig. 1From: Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer CellsCytotoxicity of free doxorubicin (DXR) and free lovastatin (LV) in breast cancer cells. In vitro cytotoxicity of free DXR, LV, and DXR and LV combined against MDA-MB-231 (a, b) and MDA-MB-453 (c, d) cancer cellsBack to article page